CXCL8 and idiopathic pulmonary fibrosis: In accord with this, recombinant IL-8 increased the proliferation of IPF MPC progeny in a dose-dependent manner (Fig. 4B), whereas the proliferation of control fibroblasts treated with recombinant IL-8 was not appreciably altered.